Date Added: 15/03/2017

Date Updated: 15/03/2017

Pembrolizumab (Keytruda) for locally advanced melanoma – adjuvant therapy

Specialties: Oncology & radiotherapy

Technology Type: Drugs

Stage of development: Investigational - phase III

Stage of EAA: Prioritised for assessment

Description, patients and keywords:

Indication

Melanoma.

Subgroup

High risk patients, post-complete resection.

Stage of disease

Stage IIIA, IIIB, IIIC.

Place in Treatment

Adjuvant.

This report is work in progress and should not be used for external distribution without permission from the originating agency. Users should be aware that reports are based on information available at the time of research and often on a limited literature search.